Mizuho Initiates Coverage On Upstream Bio with Outperform Rating, Announces Price Target of $51

Benzinga · 2d ago
Mizuho analyst Joseph Catanzaro initiates coverage on Upstream Bio (NASDAQ:UPB) with a Outperform rating and announces Price Target of $51.